Effect of Erchen Decoction (二陈汤) on Serum Leptin and Expression of LepR,POMC,and NPY in Hypothalamus of Metabolic Syndrome Model Mice with Phlegm Syndrome
|更新时间:2025-04-30
|
Effect of Erchen Decoction (二陈汤) on Serum Leptin and Expression of LepR,POMC,and NPY in Hypothalamus of Metabolic Syndrome Model Mice with Phlegm Syndrome
Journal of Traditional Chinese MedicineVol. 66, Issue 9, Pages: 948-954(2025)
YANG Menghan,LI Yuanyuan,ZHENG Xiujuan,et al.Effect of Erchen Decoction (二陈汤) on Serum Leptin and Expression of LepR,POMC,and NPY in Hypothalamus of Metabolic Syndrome Model Mice with Phlegm Syndrome[J].Journal of Traditional Chinese Medicine,2025,66(09):948-954.
YANG Menghan,LI Yuanyuan,ZHENG Xiujuan,et al.Effect of Erchen Decoction (二陈汤) on Serum Leptin and Expression of LepR,POMC,and NPY in Hypothalamus of Metabolic Syndrome Model Mice with Phlegm Syndrome[J].Journal of Traditional Chinese Medicine,2025,66(09):948-954.DOI: 10.13288/j.11-2166/r.2025.09.013.
Effect of Erchen Decoction (二陈汤) on Serum Leptin and Expression of LepR,POMC,and NPY in Hypothalamus of Metabolic Syndrome Model Mice with Phlegm Syndrome
(二陈汤, ECD) in improving metabolic syndrome (MS) with phlegm syndrome.
Methods
2
Forty mice were randomly divided into a blank group of 10 mice and a modeling group of 30 mice. The MS model with phlegm syndrome was induced in the modeling group by high-fat diet. Thirty successfully modeled mice were randomly divided into a model group, a ECD group, and a metformin group, with 10 mice in each group. The ECD group was given 0.4 g/(kg·d) of ECD, while the metformin group was intervened with 11.1 g/(kg·d) of metformin solution, and the blank group and the model group were given 0.02 ml/(g·d) of sterilized drinking water, all by gavage, once daily for 4 weeks. Body weight, abdominal circumfe-rence, body length, Lee's index and food intake were recorded. Blood glucose and blood lipid levels including fasting blood glucose, triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured. ELISA was used to detect serum leptin levels, while HE staining was used to observe liver pathological changes. Western Blot and q-PCR were used to detect protein and mRNA expression of hypothalamic leptin receptor (LepR), pro melanocortin (POMC), and neuropeptide Y (NPY) in the hypothalamus. Immunofluorescence was used to detect fluorescence expression of POMC and NPY in the hypothalamic arcuate nucleus region.
Results
2
Pathological results showed that the mice in the model group had numerous fat vacuoles in hepatocytes and significant liver fat deposition, while the ECD and metformin groups showed reduced fat vacuoles and le
ss liver fat deposition. Compared to those in the blank group, the mice in the model group mice showed liver fat deposition, increased body weight, abdominal circumference, Lee's index and food intake; fasting blood glucose, TG, TC, LDL-C, and serum leptin levels were elevated, while HDL-C was decreased; the expression of LepR, POMC protein levels and their mRNA expression decreased, while the protein level and mRNA expression of NPY increased; the fluorescence expression of POMC in the arcuate nucleus was reduced, while NPY fluorescence expression increased (
P
<0.05 or
P
<0.01). Compared to the model group, the ECD group and metformin group showed significant improvements in the above indicators (
P
<0.05 or
P
<0.01). Compared to the ECD group, the metformin group showed a reduction in body weight and NPY fluorescence expression, and an increase in HDL-C levels (
P
<0.05 or
P
<0.01).
Conclusion
2
ECD can downregulate serum leptin levels and improve glucose and lipid metabolism in the MS of phlegm syndrome. Its mechanism of action may be to reduce liver fat deposition and thereafter affect the expression of neuropeptides related to feeding activity in the hypothalamus.
关键词
Keywords
references
ACHILA OO , ARAYA M , BERHE AB , et al . Metabolic syndrome, associated factors and optimal waist circumfe-rence cut points: findings from a cross-sectional community-based study in the elderly population in Asmara, Eritrea [J]. BMJ Open , 2022 , 12 ( 2 ): e52296 .
MARTÍNEZ-UÑA M , LÓPEZ-MANCHEÑO Y , DIÉGUEZ C , et al . Unraveling the role of leptin in liver function and its relationship with liver diseases [J]. Int J Mol Sci , 2020 , 21 ( 24 ): 9368 .
BUETTNER C , POCAI A , MUSE ED , et al . Critical role of STAT3 in leptin's metabolic actions [J]. Cell Metab , 2006 , 4 ( 1 ): 49 - 60 .
PASANISI P , OLIVERIO A , BALDASSARI I , et al . Metformin treatment with or without mediterranean diet for the prevention of age-related diseases in people with metabolic syndrome: the mememe randomized trial [J]. Diabetes Care , 2025 , 48 ( 2 ): 265 - 272 .
OBRADOVIC M , SUDAR-MILOVANOVIC E , SOSKIC S , et al . Leptin and obesity: role and clinical implication [J]. Front Endocrinol (Lausanne) , 2021 , 12 : 585887 . doi: 10.3389/fendo.2021.585887 http://dx.doi.org/10.3389/fendo.2021.585887 .
CAVADAS C , AVELEIRA CA , SOUZA GF , et al . The pathophysiology of defective proteostasis in the hypothalamus-from obesity to ageing [J]. Nat Rev Endocrinol , 2016 , 12 ( 12 ): 723 - 733 .
LIU H , DU T , LI C , et al . STAT3 phosphorylation in central leptin resistance [J]. Nutr Metab (Lond) , 2021 , 18 ( 1 ): 39 .
ABERDEIN N , DAMBRINO RJ , CARMO JMDO , et al . Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance [J]. Am J Physiol Regul Integr Comp Physiol , 2018 , 314 ( 3 ): R478 - R488 .
Characteristics of Energy Metabolism in Serum and Liver Tissue in Metabolic Syndrome with Phlegm Syndrome Model Rats
Influence of Ziyin Qingxin Decoction on Adiponectin,Leptin,and TNF-α of Patients with Metabolic Syndrome
Biological Connotation of "Phlegm Syndrome" from the Perspective of Lipophagy Dysregulation
Analysis of Major Syndromes and Their Typical Related Symptoms and Signs in 135 Patients with Metabolic Syndrome:A Clinical Study Based on Syndrome Element Differentiation and Latent Class Analysis
WANG Xinlu's Experience in Treating Metabolic Syndrome based on “Blood Turbidity”
Related Author
Jia WEI
Hualin ZENG
Shuying LIN
Shijie QIAO
Yanfei SHAO
Candong LI
Bizhen GAO
YE Zi
Related Institution
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Fujian University of Traditional Chinese Medicine
Fujian Provincial Hospital
The First People’s Hospital of Linhai city
Research Base for Traditional Chinese Medicine Syndrome,Fujian University of Traditional Chinese Medicine